feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Ancient Chinese Medicine Boosts Births for Older Moms

Ancient Chinese Medicine Boosts Births for Older Moms

10 Feb

•

Summary

  • Chinese herbal medicine significantly increases live birth rates.
  • Nearly 23% relative increase observed in women aged 35+.
  • Research published in top journal Nature Communications.
Ancient Chinese Medicine Boosts Births for Older Moms

A significant advancement in reproductive medicine has emerged from traditional Chinese medicine (TCM). Zishen Yutai, developed by Guangzhou Baiyunshanzhongyi Pharmaceutical, has demonstrated a notable capacity to enhance live birth rates among women aged 35 and older undergoing fresh embryo transfers.

The clinical research, published in January in the prestigious journal Nature Communications, revealed a relative increase of nearly 23 percent in live births for this demographic. This marks a landmark occasion, as it's the first time the journal has featured clinical research on TCM's application in reproductive health.

The study, a randomized clinical trial involving 1,467 women across 12 tertiary hospitals in China, also reported improvements in pregnancy test rates, implantation rates, and clinical pregnancy rates. Researchers believe this validates TCM and promotes its broader international recognition, offering renewed hope for older couples struggling with fertility.

With rising numbers of older mothers, as over 18.7 percent of births in China in 2023 were to mothers aged 35 and above, this TCM medication provides a vital option. It is currently available in Macao and mainland China, highlighting the potential of integrating traditional and Western medicine.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Zishen Yutai has shown a relative increase of nearly 23 percent in live birth rates for women aged 35 and above during fresh embryo transfer cycles.
The clinical research on Zishen Yutai was published in the academic journal Nature Communications in January.
Zishen Yutai is available in the Macao market and on the Chinese mainland.

Read more news on

Healthside-arrowChinaside-arrow
trending

Salesforce lays off 1000

trending

India US trade tariffs slashed

trending

Margot Robbie's Wuthering Heights panned

trending

CBSE board exams: key details

trending

Jana Nayagan movie court case

trending

Dhakshineswar Suresh Davis Cup hero

trending

Deepika Padukone wears Gaurav Gupta

trending

NZ vs UAE match prediction

trending

iPhone 17 Croma Valentine's sale

You may also like

Eisai Licenses Henlius Lung Cancer Drug for $75M

5 Feb • 24 reads

article image

Pet Obesity Crisis: China Approves Cat Drug

2 Feb • 43 reads

article image

China's Mega Egg City: 3 Million Hens, 1 Human

31 Jan • 39 reads

article image

Son's Violin Farewell for Dying Mother

23 Jan • 59 reads

article image

Alzheimer's Blood Tests Arrive in China

14 Jan • 114 reads

article image